5 completed, 1 terminated. 3 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Cellular Sciences, inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of N115 on Coughing in IPF Patients 20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray - Idiopathic Pulmonary Fibrosis | Phase 3 | Completed | Cellular Sciences, inc. | 50 | 2023-08-15 | 2024-08-07 |
| Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers. sodium pyruvate nasal spray - Long COVID | Phase 2 / Phase 3 | Completed | Cellular Sciences, inc. | 22 | 2021-04-27 | 2022-03-09 |
| Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection Sodium Pyruvate, Saline - COVID-19 | Phase 2 / Phase 3 | Completed | Cellular Sciences, inc. | 30 | 2021-04-12 | 2022-11-02 |
| Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Sodium Pyruvate in 0.9% Sodium Chloride Solution - Cystic Fibrosis | Phase 1 | Completed | Emphycorp | 15 | 2006-03-01 | 2011-07-19 |
| A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. Inhaled Sodium Pyruvate - Cystic Fibrosis | Phase 1 | Terminated | University of Minnesota | 70 | 2006-02-01 | 2008-12-01 |
| Sodium Pyruvate Therapy in COPD Patients sodium pyruvate in 0.9% sodium chloride solution - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Completed | Emphycorp | 60 | 2004-09-01 | 2006-05-29 |
COVID-19 (2) · Cystic Fibrosis (2) · Idiopathic Pulmonary Fibrosis (1) · Post-Acute COVID-19 Syndrome (1) · Pulmonary Disease, Chronic Obstructive (1)
Sodium Chloride (3) · BASS2 protein, Arabidopsis (1)
United States (6)
Carlos E Milla, MD (1) · Joanne Billings, MD (1) · Joanne L Billings, MD, MPH (1) · John J. Votto, D.O. (1) · Manuel M Lam, MD (1) · Ronald Amen, Ph.D. (1) · Ronald Amen, PhD (1)